Maggie FitzPatrick
Board Director
MindUP™ | The Goldie Hawn Foundation
Maggie FitzPatrick is a seasoned public company director, strategic advisor, and founder of FitzPatrick & Co., where she counsels CEOs and boards on governance, organizational transformation, stakeholder trust, and the responsible adoption of artificial intelligence. She serves as Lead Independent Director and Compensation Committee Chair of AN2 Therapeutics (NASDAQ: ANTX) and is a faculty member of the National Association of Corporate Directors (NACD) Board Advisory Services.
A former Fortune 50 executive, Maggie held senior leadership roles at Johnson & Johnson, Exelon, and Cigna. At Johnson & Johnson, she led global communications across more than 260 operating companies. Earlier, at Exelon and Cigna, she oversaw corporate affairs, foundations, and philanthropic investments that advanced health, education, the arts, and community development.
Maggie brings deep civic and nonprofit leadership experience, having served as Vice Chair of the Washington, D.C. Commission on the Arts and Humanities, Trustee of the Mead Center for American Theater at Arena Stage, and a board member of Bright Beginnings, Achilles International, and the National Partnership for Women & Families. Across every role, her leadership has focused on expanding opportunity, supporting children and families, and building resilient communities.
Maggie is NACD Directorship Certified® and a graduate of the Harvard Program for Corporate Directors. She holds a master's degree in Public Policy from The George Washington University and a bachelor's degree in Policy Studies and English from Syracuse University. Her leadership has been recognized with honors including PRWeek Woman of Distinction and Washington Business Journal Top C-Suite Executive.
